NCT00300664
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +23 more
- Locations
-
Not specified
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,958 public trials
2,018 recruiting studies
Immunoproliferative Disorders trial results
NCT00378222
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
NCT00138086
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium
- Hôpital Henri Mondor Créteil, France
- Hématologie CHU de Lille Lille, France
- Institut Curie Paris, France
NCT00372242
- Conditions
- Body Weight, Body Weight Changes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
Not specified
NCT00367185
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Lille University Hospital Lille, France
NCT00082303
- Conditions
- Anxiety Disorders, Behavior, Behavioral Symptoms, +13 more
- Locations
-
- Indiana University Cancer Center/University Hospital Indianapolis, Indiana, United States
NCT00067288
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Memorial Sloan-Kettering Institute for Cancer Research New York, United States
NCT00001579
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Completed
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
NCT00001533
- Conditions
- Agranulocytosis, Anemia, Blood Platelet Disorders, +19 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
Completed
A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
NCT00096837
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States